THIS IS AACI GET INVOLVED JOIN THE FIGHT AACI PARTNERS RESOURCE TOOLS EDUCATION SHOP/GIVING

Research Programs

DCA and How It Works

Dichloroacetic acid versus Sodium Dichloroacetate

Dichloroacetic acid is a small molecule, basically acetic acid with 2 chlorines. The molecular formula is Cl2CHCOOH.

Dichloroacetate is the sodium salt of dichloroacetic acid. Replace a hydrogen with sodium and you get Cl2CHCOONa

If you view the video from CTV you will see a jar of dichloroacetic acid prominently displayed. http://www.depmed.ualberta.ca/dca/vid1.htm is well worth watching. But they used a “cheap ...powder”. Dichloroacetic acid only comes in liquid. The powder is the sodium salt of dichloroacetic acid. It is sodium dichloroacetate. The researchers did not use the acid.   READ MORE

For those of you searching for DCA, do not buy the acid. I posted info on the FAQ about it. The acid is not the same thing as the acetate. The acid is dangerously corrosive.

How does DCA work, briefly?

The Michelakis team reports that DCA turns on the mitochondria of cancer cells, allowing them to commit cellular suicide, or apoptosis.

Cancer cells shut down the mitochondria, which is the part of the cell that is involved in metabolism and, incidentally, initiates the cell suicide.

A non-cancerous cell will initiate apoptosis when it detects damage within itself that it cannot repair. But a cancer cell resists the suicide process. That is why chemotherapy and radiation treatments do not work very well and actually result in terrible side effects… the healthy cells actually die much easier.

Michelakis and his team discovered that they could re-activate the mitochondria of cancer cells. Not only that, the DCA is very effective in doing it: To quote from the Michelakis paper: “The decrease in [Ca2+]i occurs within 5 min and is sustained after 48 hr of DCA exposure.” The mitochondria are so sensitive to DCA that just 5 minutes of exposure reactivates them for 48 hours.
http://www.thedcasite.com/dca_how_it_works.html

Resveratrol May Prevent Breast Cancer

July 7, 2008 -- Resveratrol, a nutrient found in red wine, keeps estrogen from causing breast cancer in test-tube studies.

Prolonged exposure to estrogen is a major risk factor for breast cancer. Most research has focused on the interactions between estrogen and estrogen receptors on breast cancer cells.   READ MORE

But when the body's system for processing estrogen gets out of balance, dangerous estrogen metabolites appear. These toxic compounds react with DNA in breast cells and jump-start the growth of tumors.

Now Eleanor G. Rogan, PhD, and colleagues at the University of Nebraska show that resveratrol decreases the processing of estrogen into these dangerous compounds. Perhaps more importantly, it also blocks interactions between estrogen metabolites and cellular DNA.

And that's not all. Rogan's team finds that resveratrol increases production of an enzyme that destroys dangerous estrogen metabolites.

"Resveratrol has the ability to prevent the first step that occurs when estrogen starts the process that leads to cancer," Rogan says in a news release. "We believe that this could stop the whole progression that leads to breast cancer down the road."

The Rogan team's findings come from studies of human breast cells grown in the laboratory. It's a long way from showing that resveratrol can actually prevent cancer in women.
http://www.webmd.com/breast-cancer/news/20080707/resveratrol-may-prevent-breast-cancer

Research Opportunities

As our ongoing commitment to excellence in research, the Best Case Series was created to track and document the effectiveness of Poly-MVA (a dietary supplement) with cancer and quality of life.   READ MORE

We are gathering data on patients who voluntarily elect to:

1. Refuse any conventional treatment and take only Poly-MVA
2. Take Poly-MVA with conventional treatment who have previously failed conventional treatment
3. Take Poly-MVA alone after failing conventional treatment
4. Take Poly-MVA with a conventional treatment with a very poor success rate

These patients must be monitored closely for the duration of the case study with customary laboratory and imaging data. The patient may withdraw from the study at any time and elect to use conventional treatment at any time during the study. For those patients who have financial hardship, Poly-MVA is available with assistance from Charity Research Organizations.
http://www.facr.org/research.html

Dogs Excel on Smell Test to Find Cancer

In the small world of people who train dogs to sniff cancer, a little-known Northern California clinic has made a big claim: that it has trained five dogs -- three Labradors and two Portuguese water dogs -- to detect lung cancer in the breath of cancer sufferers with 99 percent accuracy.   READ MORE

The study was based on well-established concepts. It has been known since the 80's that tumors exude tiny amounts of alkanes and benzene derivatives not found in healthy tissue.

Other researchers have shown that dogs, whose noses can pick up odors in the low parts-per-billion range, can be trained to detect skin cancers or react differently to dried urine from healthy people and those with bladder cancer, but never with such remarkable consistency.

The near-perfection in the clinic's study, as Dr. Donald Berry, the chairman of biostatistics at M. D. Anderson Cancer Center in Houston, put it, ''is off the charts: there are no laboratory tests as good as this, not Pap tests, not diabetes tests, nothing.''
http://query.nytimes.com/gst/fullpage.html?res=9807E6DA143FF934A25752C0A9609C8B63&sec=health&spon=&pagewanted=1

Cancer Cover Up

Mass spectrographic and isotope studies have shown that potassium, rubidium, and especially cesium are most efficiently taken up by cancer cells. This uptake was enhanced by Vitamins A and C as well as salts of zinc and selenium. The quantity of cesium taken up was sufficient to raise the cell to the 8 pH range.   READ MORE

Where cell mitosis ceases and the life of the cell is short. Tests on mice fed cesium and rubidium showed marked shrinkage in the tumor masses within 2 weeks. In addition, the mice showed none of the side effects of cancer. Tests have been carried out on over 30 humans. In each case the tumor masses disappeared. Also all pains and effects associated with cancer disappeared within 12 to 36 hr; the more chemotherapy and morphine the patient had taken, the longer the withdrawal period. Studies of the food intake in areas where the incidences of cancer are very low showed that it met the requirements for the high pH therapy.
http://www.cancer-coverup.com/brewer/default.html

Kanzius Cancer Research Foundation

The Kanzius Cancer Research Foundation regretfully announces the passing of John Kanzius on Wednesday, February 18, 2009. John’s passing, at a hospital near his winter home in Sanibel, Florida, has come at a time when his cancer invention was entering the final stages of animal testing and nearing the time when it would become available for human clinical trials.   READ MORE

“We will not stop until John’s vision becomes reality,” said Maryann Yochim, president of the Kanzius Cancer Research Foundation. “Our only regret at this point is that John will not be here to see the first cancer patient cured with his technology. But, we believe strongly that this will happen. It’s only a matter of time.”

Lead researcher, Steven Curley, MD will continue his work at a lab at the M.D. Anderson Cancer Center, which is dedicated specifically to John’s invention. Your donations have helped to increase the number of researchers working on this project and will continue to provide the funds necessary to see it to completion.

We remain committed to John’s mission to find a cure for cancer. With the continued dedication of the Rutkowski family at Industrials Sales and Manufacturing, in Erie, PA, who have devoted countless hours towards this mission, we are confident that someday John’s dream will become a reality. Your continued support will help to ensure John’s legacy.

(Note: Be sure to watch the videos on this site.)
http://www.kanziuscancerresearch.com/


DISCLAIMER:
This website is for educational purposes only. It is not intended as a substitute for the diagnosis, treatment or advice of a qualified, licensed professional. This site offers medical data and informs about alternative medical options. No one should consider that this site represents the "practice of medicine." This site assumes no responsibility for how the material herein is used. Please note that this website is constantly updating its content and, therefore, some of the information may be dated. Also, be advised that the statements regarding alternative treatments for cancer have not been evaluated by the FDA.
THIS IS AACI GET INVOLVED JOIN THE FIGHT AACI PARTNERS RESOURCE TOOLS EDUCATION SHOP/GIVING